Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine

doi:10.4251/wjgo.v13.i10.1518

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5923)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

318

WORD

110

HTML

2912

Figures (1-5)

172

Tables (1-3)

206

Sum=3718

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

534

Download

1671

Sum=2205

Oct 15, 2021 (publication date) through Dec 19, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1518-1531
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1518

Full Size Figure Download Figure

Figure 1 Experimental design. This figure shows a diagram of the treatment received by each group of animals. In all cases the treatment was continued until the moment of euthanasia or the end of their life. This figure is original for this work. DMH: 1,2-Dimethylhidrazine dihydrochloride; EDTA: Ethylene diamine tetra-acetic acid.

Citation: Gigola G, Carriere P, Novoa Díaz MB, Perdigon G, Zwenger AO, Gentili C. Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine. World J Gastrointest Oncol 2021; 13(10): 1518-1531
URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1518.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1518